EANM 2011—Welcome to Birmingham!Tools Langsteger, Werner (2011) EANM 2011—Welcome to Birmingham! European Journal of Nuclear Medicine, 38 (Suppl2). p. 79.
Text (EANM 2011—Welcome to Birmingham!)
1 - 2011 EJNMMI Langsteger Editorial.pdf Restricted to Registered users only Download (58kB) AbstractOn behalf of the European Association of Nuclear
Medicine, I am very honoured and pleased to welcome
you to Birmingham for the 24th Annual EANM
Congress, 2011. Following the successful Vienna 2010
congress, this is the second time that I have had the
privilege of organising the scientific programme for the
annual congress. The Scientific Committee and the
British Society of Nuclear Medicine have assisted greatly
in this task, and I believe that together we have devised a
programme that will be attractive for both physicians and
scientists.
In organising this congress in Birmingham, our principal
scientific focus has been on the organisation, in conjunction
with other European medical societies, of numerous joint
meetings and interdisciplinary symposia. Particularly the
development and application of hybrid imaging has led to
the recognition that nuclear medicine should, indeed must,
be a cooperative enterprise rather than pursued in isolation.
It is not going too far to suggest that it has become our
duty to ensure that this goal is achieved. It is naturally
self-evident that within our community, with our nuclear
medicine methods and findings, we must strive to maintain a
high scientific level. Nevertheless, the decisive factor in the
future of our specialty will be the clinical marketing of
nuclear medicine—the ability to establish, adequately and
above all with sufficient self-confidence, the importance of
nuclear medicine in the minds of our clinical partners,
referring physicians and sister disciplines. This represents
one of the immediate and medium-term challenges for
nuclear medicine that needs to be addressed in order to
ensure that our specialty receives efficient, timely and
advantageous representation on, for example, oncological
tumour boards and neurology and cardiology grand rounds.
An important first step in this direction is to develop a
suitably fair partnership with the radiologists in order to
improve and/or further refine and consolidate the PET/CT
results achieved to date. In addition, however, the application
of PET-MRI in particular may be expected to require
still deeper cooperation in the future, given that joint
design and implementation of MRI and PET protocols as
well as procedures is a prerequisite for optimal utilisation
of the technique and maximisation of patient benefit. In
addition, extensive cooperation with the oncologists will
be necessary, especially in the new field of theranostics, in
order to achieve the earliest possible wider use of nuclear
medicine diagnosis and therapy in tumour patients.
Some Statistics on the Birmingham Meeting
The present status and future prospects of Nuclear
Medicine will be discussed in four plenaries (including
the Marie Curie and Highlights Lecture), seven symposia,
six joint symposia with related societies and associations
(ESTRO, EAU, ESR, SNM, EORTC, ETA) and 13
Continuing Medical Education sessions.
Moreover, various daily sessions successfully launched at
last year’s Congress, namely the EANM Breakfast Session
sponsored by the industry (starting at 7:00 a.m.), The
Expert’s View Session (Pitfalls, Artefacts & Physiology—
Interactive, starting at 8:00 a.m.) and the Young EANM Daily
Forum (starting at 1:00 p.m.) have again been organised.
Overall a total of 1,667 abstracts were submitted, of which
1,475 were finally accepted, representing a rejection rate of
about 11.5%. During the meeting, 532 oral presentations and
968 posters will be presented in 13 featured sessions, 51
parallel sessions and 15 technologist sessions.
On behalf of the EANM Executive Committee, the Local
Organising and Scientific Committee and the EANM “Headquarters”
in Vienna, it is my pleasure to welcome you to the
Congress and to wish you all a pleasant stay in Birmingham.
Actions (login required) |
||||||||||||||
|